<--- Back to Details
First PageDocument Content
United States patent law / Civil law / Law / Property law / Patent law / EU patent / Patent Reform Act / Intellectual property law / Monopoly / Patent
Date: 2014-05-21 18:16:36
United States patent law
Civil law
Law
Property law
Patent law
EU patent
Patent Reform Act
Intellectual property law
Monopoly
Patent

May  20,  2014 Dear  Members  of  the  Senate  Judiciary  Committee: We  the  undersigned  groups  representing  thousands  of  innovative  companies,  universities,   and  organizations  and  milli

Add to Reading List

Source URL: www.washingtonpost.com

Download Document from Source Website

File Size: 103,63 KB

Share Document on Facebook

Similar Documents

PRESS RELEASE  March 19, 2008 European Business Leaders Call for a Simplified Patent Process to Drive Innovation Europe’

PRESS RELEASE March 19, 2008 European Business Leaders Call for a Simplified Patent Process to Drive Innovation Europe’

DocID: 1szK3 - View Document

PRES SEMI TTE ILUN G IDnow wird Europameister: Erstes Patent für Video-Identifizierung EU vereinheitlicht digitalen Vertragsabschluss zum 1. Juli 2016, IDnow hat die passende Lösung München, 1. Juni 2016 – Europawei

PRES SEMI TTE ILUN G IDnow wird Europameister: Erstes Patent für Video-Identifizierung EU vereinheitlicht digitalen Vertragsabschluss zum 1. Juli 2016, IDnow hat die passende Lösung München, 1. Juni 2016 – Europawei

DocID: 1s15r - View Document

für käse  Wir haben das Patent...  ... Sie haben

für käse Wir haben das Patent... ... Sie haben

DocID: 1ruux - View Document

SINGLE RESOLUTION BOARD VACANCY NOTICE SENIOR LEGAL EXPERT IN BANKING REGULATION AND RESOLUTION (SRB/ADType of contract

SINGLE RESOLUTION BOARD VACANCY NOTICE SENIOR LEGAL EXPERT IN BANKING REGULATION AND RESOLUTION (SRB/ADType of contract

DocID: 1rrDz - View Document

27 JANUARY 2016 BIOSIMILARS DEVELOPMENT - FROM PRE-CLINIC TO MARKET Several biological products, altogether worth over US$60 billion annual sales, are encountering patent expiry byThis opens up the opportunity for

27 JANUARY 2016 BIOSIMILARS DEVELOPMENT - FROM PRE-CLINIC TO MARKET Several biological products, altogether worth over US$60 billion annual sales, are encountering patent expiry byThis opens up the opportunity for

DocID: 1rnQJ - View Document